Extension Study to 810P202
This study is completed in the United States. It focuses on ADHD.
Multiple locations, including Dothan
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It focuses on ADHD.
Multiple locations, including DothanThis study is completed in the United States. It is testing cariprazine for schizophrenia.
Multiple locations, including DothanThis study is completed in Austria. It is testing trazodone Hydrochloride for depression.
In AustriaThis study is completed in Bulgaria. It is testing cariprazine for schizophrenia.
In BulgariaThis study is completed in the United Kingdom. It is testing concomitant Megestrol + Formoterol for Eating disorders.
In United KingdomThis study is completed in Belgium. It is testing paliperidone ER for Schizophrenia.
In BelgiumThis study is completed in the United States. It focuses on ADHD.
In New YorkThis study is ongoing in Spain. It is testing aripiprazole vs paliperidone / risperidone using multi-omics data for Schizophrenia.
In SpainThis summary needs review. Please check the official study record and contact the research team for details.
In StanfordThis summary needs review. Please check the official study record and contact the research team for details.
In DenverThis observational study is following people with depression or anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
Multiple locations, including EncinitasThis summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.